Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Endocr Pathol ; 20(1): 35-40, 2009.
Artigo em Inglês | MEDLINE | ID: mdl-19172414

RESUMO

The present study reports the case of a 70-year-old Caucasian man who was referred to the Military Hospital of Buenos Aires for evaluation of a giant sellar-extrasellar mass with extension in the right temporal lobe and compression of the third ventricle. Patient was initially responsive to cabergoline with reduction of prolactin levels and shrinkage of tumor burden for at least 36 months. Thereafter, prolactin levels and tumor size increased even though cabergoline dosage was increased. Transcraneal surgery was performed at 56 months of treatment. Prolactin levels and tumor proliferation did not subside and the patient died 14 months later. High GH and IGF-I levels were observed in the late stages of tumor development, with no evidence of acromegalic features. Immunohistochemistry of the excised tumor revealed strong immunoreactivity for VEGF and FGF-2, two potent angiogenic factors, and CD31 (an endothelial marker) indicating high vascularization of the adenoma.


Assuntos
Antineoplásicos/uso terapêutico , Resistencia a Medicamentos Antineoplásicos/genética , Ergolinas/uso terapêutico , Neovascularização Patológica/metabolismo , Neoplasias Hipofisárias/patologia , Prolactinoma/patologia , Idoso , Biomarcadores Tumorais/análise , Cabergolina , Humanos , Hipotireoidismo , Imuno-Histoquímica , Imageamento por Ressonância Magnética , Masculino , Neoplasias Hipofisárias/tratamento farmacológico , Neoplasias Hipofisárias/metabolismo , Prolactina/sangue , Prolactinoma/tratamento farmacológico , Prolactinoma/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA